Atlas Trials

Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL

Clinical trial NCT07120633 · RECRUITING

Trial details

NCT number
NCT07120633
Sponsor
The Affiliated Hospital of Xuzhou Medical University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
CLLCAR-T Cell TherapySLL
Start date
2025-09-01
Primary completion
2028-09-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.